Edwards Lifesciences (EW) Shareholder's Equity Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.26% |
| Dec 31, 2025 | 17.71% |
| Sep 30, 2025 | 19.37% |
| Jun 30, 2025 | 22.54% |
| Mar 31, 2025 | 21.17% |
| Dec 31, 2024 | 19.39% |
| Sep 30, 2024 | 20.30% |
| Jun 30, 2024 | 16.48% |
| Mar 31, 2024 | 15.82% |
| Dec 31, 2023 | 16.43% |
| Sep 30, 2023 | 14.89% |
| Jun 30, 2023 | 15.30% |
| Mar 31, 2023 | 13.31% |
| Dec 31, 2022 | 14.46% |
| Sep 30, 2022 | 14.48% |
| Jun 30, 2022 | 15.12% |
| Mar 31, 2022 | 16.34% |
| Dec 31, 2021 | 17.38% |
| Sep 30, 2021 | 15.54% |
| Jun 30, 2021 | 15.74% |
| Mar 31, 2021 | 15.17% |
| Dec 31, 2020 | 12.82% |
| Sep 30, 2020 | 11.70% |
| Jun 30, 2020 | 10.90% |
| Mar 31, 2020 | 12.00% |
| Dec 31, 2019 | 13.61% |
| Sep 30, 2019 | 13.30% |
| Jun 30, 2019 | 12.82% |
| Mar 31, 2019 | 20.79% |
| Dec 31, 2018 | 15.25% |
| Sep 30, 2018 | 18.52% |
| Jun 30, 2018 | 14.90% |
| Mar 31, 2018 | 15.31% |
| Dec 31, 2017 | 15.04% |
| Sep 30, 2017 | 15.53% |
| Jun 30, 2017 | 15.43% |
| Mar 31, 2017 | 14.55% |
| Dec 31, 2016 | 14.56% |
| Sep 30, 2016 | 14.72% |
| Jun 30, 2016 | 12.27% |
| Mar 31, 2016 | 11.11% |
| Dec 31, 2015 | 13.86% |
| Sep 30, 2015 | 14.44% |
| Jun 30, 2015 | 15.41% |
| Dec 31, 2014 | 13.61% |